VALE (VALE)

$65.7B
Market Cap
27.6
P/E Ratio
0.94
Beta
8.37%
Dividend Yield
Piotroski 5/9Altman Z 1.5 DistressBeneish M -2.78 CleanROIC−WACC -1.6%

Quantitative Summary

Deterministic

Financial health is average: Piotroski 5/9, Altman Z 1.5.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The fundamental economics of the company reveal a capital allocation challenge, evidenced by an ROIC-WACC spread of -1.6%, indicating that current investments are destroying value relative to the cost of capital. Despite this negative spread, profitability metrics remain robust with a 35.0% gross margin and a net margin of 6.1%, suggesting strong pricing power or operational efficiency in core segments. However, equity returns rely heavily on leverage rather than organic growth drivers, as revenue expansion has stagnated at just 0.9% year-over-year. Financial health indicators present a mixed picture; while the Beneish M-Score of -2.78 signals low earnings manipulation risk and the Piotroski F-Score of 5/9 reflects moderate financial strength, an Altman Z-Score of 1.5 flags elevated bankruptcy distress risks that warrant close monitoring during periods of market stress.

Valuation metrics suggest a significant divergence between current pricing and intrinsic value estimates. The stock trades at a forward P/E multiple of 27.6x, which appears stretched given the lack of meaningful revenue growth and negative capital efficiency spreads. This premium valuation conflicts sharply with DCF modeling that implies a fair value of $4 per share, suggesting the market is currently pricing in unrealistic future growth assumptions or ignoring the drag on returns caused by the ROIC-WACC gap. Unless earnings quality improves substantially to justify such multiples through higher margins or accelerated turnover, the current price level may not reflect the underlying cash flow generation capabilities supported by the provided fundamentals.

While specific risk factor deltas and insider activity data were not supplied in this dataset, the combination of a distress-level Altman Z-Score and negative capital efficiency creates an asymmetric risk profile for long-term holders. The absence of revenue growth alongside high valuation multiples implies that any downside catalyst related to operational execution or commodity price volatility could trigger a rapid re-rating toward lower valuations consistent with the DCF fair value estimate. Investors must weigh whether current market sentiment is sufficiently discounting these fundamental headwinds before committing capital at present levels.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →7.1%9.1%11.1%
2%$6$4$2
3%$8$4$3
4%$11$6$3

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=9.1%, terminal growth 3%. Fair value $4 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

5/9
Piotroski F-Score
Average — mixed operational signals
1.5
Altman Z-Score
Distress Zone — below 1.8 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.78
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

35.0%
Gross Margin
6.1%
Net Margin
7.5%
ROIC
9.1%
WACC
ROIC − WACC Spread: -1.6%— Negative spread.
+0.9%
Revenue Growth (YoY)
-61.9%
Earnings Growth (YoY)
2.8B
Free Cash Flow
127%
FCF Payout Ratio

⚠️ Dividend consumes >80% of FCF — sustainability risk.

Balance Sheet Health

1.52x
Debt / Equity
1.15x
Current Ratio
3.3x
Interest Coverage
1.4x
Net Debt / EBITDA
3.54%
FCF Yield
9.8B
EBITDA

Earnings Surprise History

Q4
✗ Miss
Est: $0.41
Act: $0.35
-14.5%
Q3
✓ Beat
Est: $0.36
Act: $0.50
+37.9%
Q2
✓ Beat
Est: $0.52
Act: $0.64
+22.9%
Q1
✗ Miss
Est: $0.63
Act: $0.34
-45.2%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

7.0
Forward P/E
PEG Ratio
1.84
Price/Book
38M
Avg Volume
$17.72
52W High
$8.06
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$77M
Tracked Passive Exposure
2
ETFs Holding VALE
0.43%
Avg Weight in ETFs
$18B
Total ETF AUM

When investors buy or sell ETFs like SPEM or CWI, the fund manager is mechanically forced to buy or sell VALE shares regardless of VALE's individual fundamentals. We estimate $77M of passive capital is structurally linked to VALE through 2 tracked ETFs. Passive flows have a limited but growing influence on VALE's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 2 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in VALE to visualize passive redemption contagion across ETFs and collateral stocks.

VALE Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
VALEEpicenterSPEMETFCWIETFTSMLow Risk700Unknown9988UnknownSMSNUnknown2454Unknown
VALE Price Drop (%)0

If VALE (VALE) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies TAIWAN SEMICONDUCTOR SP ADR (TSM) as the most exposed collateral stock, sharing 1 ETFs with VALE. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 2 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

VALE Ownership Dynamics

Ticker
VALE

ETFs with Highest VALE Exposure

Float lock-up computed from 2 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

VALE Capital Efficiency

How efficiently does VALE convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$2.8B
EBITDA
$9.8B
FCF Conversion
29%
Reinvestment Rate
71%
29% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
7.5%
ROIC − WACC Spread
-1.6%

VALE converts 29% of its EBITDA into free cash flow, a moderate conversion rate — significant EBITDA is consumed by capital expenditures, working capital changes, or interest payments. The 71% reinvestment rate signals aggressive capacity expansion. However, the ROIC-WACC spread is negative (-1.6%), suggesting reinvested capital is destroying shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-13509$17.03$8,668.27
2026-05-1260$17.07$1,024.2
2026-05-0824,814$16.19$401,738.66
2026-05-071,027$16.49$16,935.23
2026-05-0538,620$15.84$611,740.8
2026-05-044,382$16.18$70,900.76
2026-05-0116,067$16.36$262,856.12
2026-04-282,056$17.07$35,095.92
2026-04-272,489$17.17$42,736.13
2026-04-244,305$17.14$73,787.7
2026-04-221$17.45$17.45
2026-04-215,204$17.82$92,735.28
2026-04-20900$17.78$16,002
2026-04-151,328$17.68$23,479.04
2026-04-144,115$17.45$71,806.75
2026-04-139,019$16.96$152,962.24
2026-04-076,072$16.14$98,002.08
2026-04-06323$16.19$5,229.37
2026-04-0219,983$16.05$320,727.15
2026-04-0176,045$15.91$1.2M
2026-03-26575,625$15.14$8.7M
2026-03-254,477$14.87$66,572.99
2026-03-2340,715$14.05$572,045.75
2026-03-207,449$14.63$108,978.87
2026-03-1911,998$14.69$176,250.62
2026-03-0323,823$16.99$404,752.77
2026-02-265,583$17.53$97,869.99
2026-02-242,825$16.92$47,799
2026-02-1976$16.00$1,216
2026-02-18447$15.90$7,107.3

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare VALE to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.